Cleared Traditional

K932369 - UROPAPER EIKEN 7

K932369 is an FDA 510(k) clearance for UROPAPER EIKEN 7, manufactured by Tanabe U.S.A., Inc.. The device is a Class 2 Chemistry device with product code JIL cleared through the Traditional 510(k) pathway after a 211-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 1993
Decision
211d
Days
Class 2
Risk

K932369 is an FDA 510(k) clearance for the UROPAPER EIKEN 7. Classified as Method, Enzymatic, Glucose (urinary, Non-quantitative) (product code JIL), Class II - Special Controls.

Submitted by Tanabe U.S.A., Inc. (San Diego, US). The FDA issued a Cleared decision on November 16, 1993 after a review of 211 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1340 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K932369

510(k) Number K932369 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 19, 1993
Decision Date November 16, 1993
Days to Decision 211 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
122d slower than avg
Panel avg: 89d · This submission: 211d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

JIL Device Classification - Class 2, Special Controls

Product Code JIL Method, Enzymatic, Glucose (urinary, Non-quantitative)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1340
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - JIL Method, Enzymatic, Glucose (urinary, Non-quantitative)

All 80
Devices cleared under the same product code (JIL) and FDA review panel - the closest regulatory comparables to K932369.
UROPAPER EIKEN GK
K932363 · Tanabe U.S.A., Inc. · Nov 1993
UROPAPER EIKEN GP
K932364 · Tanabe U.S.A., Inc. · Nov 1993
UROPAPER EIKEN 8
K932367 · Tanabe U.S.A., Inc. · Nov 1993
CHEMSTRIP(R) 10 WITH SG URINE TEST STRIPS
K896454 · Boehringer Mannheim Corp. · Jan 1990
CHARISE CHARLES REAGENT STRIPS
K895282 · Lee Import Domestic Consulting · Jan 1990
DIABETES RISK DETECTOR
K864544 · Pearce Clinical Laboratories, Inc. · Jul 1987